Brief: ZMI Pharma Finalized Acquisition Of All Strategic Assets Necessary To Manufacture Zimhi From Dmk Pharma
June 20 (Reuters) -
* ZMI PHARMA: FINALIZED ACQUISITION OF ALL STRATEGIC ASSETS
NECESSARY TO MANUFACTURE ZIMHI FROM DMK PHARMACEUTICALS
* ZMI PHARMA: TO RESUME MANUFACTURE OF ZIMHI FROM NEW
PRODUCTION
FACILITY IN CARLSBAD IN OCTOBER
Source text for Eikon: ID:nPn99sJtpa
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DMK Pharmaceuticals
See all newsBrief: Dmk Pharmaceuticals Corp Says Ebrahim Versi Resigned As Chairman
Brief: ZMI Pharma Finalized Acquisition Of All Strategic Assets Necessary To Manufacture Zimhi From Dmk Pharma
Brief: DMK Pharmaceuticals Files For Chapter 11 Bankruptcy In The U.S. - Court Filing
Brief: Dmk Pharmaceuticals Regains Full Rights To Commercialize Zimhi
Brief: DMK Pharmaceuticals Regains Full Rights From US Worldmeds For Symjepi And Provides Corporate Update